A review of uric acid, crystal deposition disease, and gout.
about
Hyperuricaemia with deposition: latest evidence and therapeutic approachThe management of goutEvolution of gout: "malignant" change over time?Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemiaOverview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.Effects of multiple genetic loci on the pathogenesis from serum urate to gout.Febuxostat for the chronic management of hyperuricemia in patients with gout.Uric acid transporters hiding in the intestine.Recent advances in understanding and managing goutLesinurad: A Review in Hyperuricaemia of Gout.Hyperuricemia in Tendons.A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial.Effects of Mollugo pentaphylla extract on monosodium urate crystal-induced gouty arthritis in mice.An optimal ultrasonographic diagnostic test for early gout: A prospective controlled study.Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity.Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor.Management of hyperuricemia through dietary polyphenols as a natural medicament: A comprehensive review.Low-Purine Diet Is More Effective Than Normal-Purine Diet in Reducing the Risk of Gouty Attacks After Sleeve Gastrectomy in Patients Suffering of Gout Before Surgery: a Retrospective Study.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.Antigout Effects of Plantago asiatica: Xanthine Oxidase Inhibitory Activities Assessed by Electrochemical Biosensing Method.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.Fluorescence turn-on detection of uric acid by a water-stable metal–organic nanotube with high selectivity and sensitivity
P2860
Q26775759-93D808C7-C367-4A9F-8242-571810B76838Q28069759-1E8122E1-6CE4-446A-98FC-628D61014397Q30392409-16771133-14C6-409C-8DB0-11A3AB047ED2Q33795758-8CDE727D-179F-4112-9428-3057B835A3DCQ34538414-6591043A-7D2C-491E-BC01-90DEC78880EFQ37080656-97B77B4A-3E21-4E2E-AA73-AD2776820A62Q37677057-D11E1F41-95E4-440B-9921-0CB7F5BD3193Q38760404-08ECEB8D-A919-4084-84F4-BD84A4D0B00BQ38827603-A68892FF-C515-4BEC-B593-FC03D2B2ACF8Q39207801-68A26093-601E-477E-B5AB-65CE9857FB85Q39251437-A7B1936C-FBEC-4B55-AFBE-04EB19B4AC06Q39480194-D6F10DC7-6F60-4033-8A85-4C11F74B7157Q40311349-FEC5E641-DE4C-4097-9BBC-5D1C837C7A71Q40385980-AD328A00-8BDE-4797-BE55-EEB220C7E622Q41625264-60C3804D-86B4-4D97-B43A-9BB8E501D27BQ41932390-677C560A-B105-4955-932B-85DCDC85C7B9Q45959502-E0F38784-BDE3-4ECA-A927-D60CDA5BA8FBQ46403916-FFE34877-B901-49AF-AB0C-8E219BE728E1Q47150749-9123406D-6FC1-4E56-989F-921CD9FB12CCQ47218264-090BA956-1469-46FC-B5AB-3F8C2CDCE89EQ47736608-F6ED29FA-AF63-4069-9912-0A646F32763CQ53837944-BC648A01-4338-4527-84CD-B1B99F24DEF3Q54996533-D3F27008-F05C-48A6-A7B5-0FC3B59730ADQ55286574-961A6C16-EE1C-462C-9373-BC95946AADF8Q55334448-F9E0CAA6-841E-4032-9D5A-A4F470B52436Q57815480-98E87F25-D07B-4F68-959D-3345627FCBAD
P2860
A review of uric acid, crystal deposition disease, and gout.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A review of uric acid, crystal deposition disease, and gout.
@ast
A review of uric acid, crystal deposition disease, and gout.
@en
type
label
A review of uric acid, crystal deposition disease, and gout.
@ast
A review of uric acid, crystal deposition disease, and gout.
@en
prefLabel
A review of uric acid, crystal deposition disease, and gout.
@ast
A review of uric acid, crystal deposition disease, and gout.
@en
P2860
P50
P921
P1433
P1476
A review of uric acid, crystal deposition disease, and gout.
@en
P2860
P2888
P356
10.1007/S12325-014-0175-Z
P407
P577
2014-12-23T00:00:00Z
2015-01-01T00:00:00Z
P5875
P6179
1029926466